Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines

Vaccines provide substantial safety against infectious diseases, saving millions of lives each year. The recent COVID-19 pandemic highlighted the importance of vaccination in providing mass-scale immunization against outbreaks. However, the delivery of vaccines imposes a unique set of challenges due to their large mo-lecular size and low room temperature stability. Advanced biomaterials and delivery systems such as nano-and mciro-scale carriers are becoming critical components for successful vaccine development. In this review, we provide an updated overview of recent advances in the development of nano-and micro-scale carriers for controlled delivery of vaccines, focusing on carriers compatible with nucleic acid-based vaccines and therapeutics that emerged amid the recent pandemic. We start by detailing nano-scale delivery systems, focusing on nanoparticles, then move on to microscale systems including hydrogels, microparticles, and 3D printed microneedle patches. Additionally, we delve into emerging methods that move beyond traditional needle-based applications utilizing innovative delivery systems. Future challenges for clinical translation and manufacturing in this rapidly advancing field are also discussed.

Automated summary

This review provides an updated overview of recent advances in the development of nano-and micro-scale carriers for controlled delivery of vaccines, with a focus on carriers compatible with nucleic acid-based vaccines and therapeutics. The review details nano-scale delivery systems, including nanoparticles, as well as microscale systems such as hydrogels, microparticles, and 3D printed microneedle patches. The review also discusses emerging methods utilizing innovative delivery systems and future challenges in clinical translation and manufacturing in this field.